2,203
Views
7
CrossRef citations to date
0
Altmetric
Research Paper

Trends in all-cause pneumonia and otitis media in children aged <2 years following pneumococcal conjugate vaccine introduction in Colombia

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, , , , & show all
Pages 1173-1180 | Received 24 Apr 2020, Accepted 31 Jul 2020, Published online: 23 Sep 2020

References

  • Valenzuela MT, O’Loughlin R, De La Hoz F, Gomez E, Constenla D, Sinha A, Valencia JE, Flannery B, De Quadros CA. The burden of pneumococcal disease among Latin American and Caribbean children: review of the evidence. Rev Panam Salud Publica. 2009;25(3):270–79. doi:10.1590/s1020-49892009000300011.
  • Gentile A, Bardach A, Ciapponi A, Garcia-Marti S, Aruj P, Glujovsky D, Calcagno JI, Mazzoni A, Colindres RE. Epidemiology of community-acquired pneumonia in children of Latin America and the Caribbean: a systematic review and meta-analysis. Int J Infect Dis. 2012;16(1):e5–15. doi:10.1016/j.ijid.2011.09.013.
  • Bardach AE, Rey-Ares L, Calderon Cahua M, Ciapponi A, Cafferata ML, Cormick G, Gentile A. Burden of culture-confirmed pediatric pneumococcal pneumonia in Latin America and the Caribbean: a systematic review and meta-analysis. Value Health Reg Issues. 2017;14:41–52. doi:10.1016/j.vhri.2017.04.004.
  • Bardach A, Ciapponi A, Garcia-Marti S, Glujovsky D, Mazzoni A, Fayad A, Colindres RE, Gentile A. Epidemiology of acute otitis media in children of Latin America and the Caribbean: a systematic review and meta-analysis. Int J Pediatr Otorhinolaryngol. 2011;75(9):1062–70. doi:10.1016/j.ijporl.2011.05.014.
  • Pneumococcal conjugate vaccines in infants and children under 5 years of age: WHO position paper – February 2019, World Health Organization. Wkly Epidemiol Rec. 2019; 94: 85–104.
  • de Oliveira LH, Camacho LA, Coutinho ES, Martinez-Silveira MS, Carvalho AF, Ruiz-Matus C, Toscano CM. Impact and effectiveness of 10 and 13-valent pneumococcal conjugate vaccines on hospitalization and mortality in children aged less than 5 years in Latin American countries: a systematic review. PLoS One. 2016;11(12):e0166736. doi:10.1371/journal.pone.0166736.
  • Word Health Organization. Measuring impact of Streptococcus pneumoniae and Haemophilus influenzae type b conjugate vaccination. Geneva (Switzerland): WHO Document Production Services; 2012.
  • de Oliveira LH, Trumbo SP, Ruiz Matus C, Sanwogou NJ, Toscano CM. Pneumococcal conjugate vaccine introduction in Latin America and the Caribbean: progress and lessons learned. Expert Rev Vaccines. 2016;15(10):1295–304. doi:10.1586/14760584.2016.1166961.
  • Caceres DC, Ortega-Barria E, Nieto J, DeAntonio R. Pneumococcal meningitis trends after pneumococcal conjugate vaccine introduction in Colombia: an interrupted time-series analysis. Hum Vaccin Immunother. 2018;4(5):1230–33. doi:10.1080/21645515.2018.1425115.
  • Departamento Administrativo Nacional de Estadıstica [National Administrative Department of Statistics] (DANE). 2017.
  • Registro Individual de Prestación de Servicios de Salud database [Health Service Provider Individual Registration system] (RIPS). 2017.
  • Rosselli D, Rueda JD. Burden of pneumococcal infection in adults in Colombia. J Infect Public Health. 2012;5(5):354–59. doi:10.1016/j.jiph.2012.04.003.
  • Bernal O, Forero JC, Villamil Mdel P, Pino R. Data availability and morbidity profile in Colombia. Rev Panam Salud Publica. 2012;31(3):181–87. doi:10.1590/s1020-49892012000300001.
  • Rodriguez-Garcia J. Estimation of cause-specific hospital discharges from hospital lethality and population mortality in Colombia, 2006–07. Lancet. 2011;377:969–70.
  • Programa Ampliado de Inmunizaciones [National Immunization Program] (PAI) 2017.
  • RStudio. Accessed 12 August 2020. https://www.rstudio.com/products/rstudio/download-server/.
  • Alvis-Guzmán NC-RJ, Alvis-Estrada L, Cortés-Fuentes L, Silva-Travecedo L. Responsiveness of the territorial governments and society face the winter season 2010–2011 in the Colombian Caribbean region: a multi-method approach. Rev Gerenc Polit Salud Bogotá (Colombia). 2013;12:10–25.
  • Suarez V, Michel F, Toscano CM, Bierrenbach AL, Gonzales M, Alencar AP, Ruiz Matus C, Andrus JK, de Oliveira LH. Impact of pneumococcal conjugate vaccine in children morbidity and mortality in Peru: time series analyses. Vaccine. 2016;34(39):4738–43. doi:10.1016/j.vaccine.2016.07.027.
  • Diaz J, Terrazas S, Bierrenbach AL, Toscano CM, Alencar GP, Alvarez A, Valenzuela MT, Andrus J, Del Aguila R, Hormazábal JC, et al. Effectiveness of the 10-valent pneumococcal conjugate vaccine (PCV-10) in children in chile: a nested case-control study using nationwide pneumonia morbidity and mortality surveillance data. PLoS One. 2016;11(4):e0153141. doi:10.1371/journal.pone.0153141.
  • Schuck-Paim C, Taylor RJ, Alonso WJ, Weinberger DM, Simonsen L. Effect of pneumococcal conjugate vaccine introduction on childhood pneumonia mortality in Brazil: a retrospective observational study. Lancet Glob Health. 2019;7(2):e249–e56. doi:10.1016/S2214-109X(18)30455-8.
  • Andrade AL, Afonso ET, Minamisava R, Bierrenbach AL, Cristo EB, Morais-Neto OL, Policena GM, Domingues CMAS, Toscano CM. Direct and indirect impact of 10-valent pneumococcal conjugate vaccine introduction on pneumonia hospitalizations and economic burden in all age-groups in Brazil: a time-series analysis. PLoS One. 2017;12(9):e0184204. doi:10.1371/journal.pone.0184204.
  • Afonso ET, Minamisava R, Bierrenbach AL, Escalante JJ, Alencar AP, Domingues CM, Morais-Neto OL, Toscano CM, Andrade AL. Effect of 10-valent pneumococcal vaccine on pneumonia among children, Brazil. Emerg Infect Dis. 2013;9(4):589–97. doi:10.3201/eid1904.121198.
  • Scotta MC, Veras TN, Klein PC, Tronco V, Polack FP, Mattiello R, Pitrez PMC, Jones MH, Stein RT, Pinto LA, et al. Impact of 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) on childhood pneumonia hospitalizations in Brazil two years after introduction. Vaccine. 2014;32(35):4495–99. doi:10.1016/j.vaccine.2014.06.042.
  • Sgambatti S, Minamisava R, Bierrenbach AL, Toscano CM, Vieira MA, Policena G, Andrade AL. Early impact of 10-valent pneumococcal conjugate vaccine in childhood pneumonia hospitalizations using primary data from an active population-based surveillance. Vaccine. 2016;34(5):663–70. doi:10.1016/j.vaccine.2015.12.007.
  • Sartori AL, Minamisava R, Bierrenbach AL, Toscano CM, Afonso ET, Morais-Neto OL, Antunes JLF, Cristo EB, Andrade AL. Reduction in all-cause otitis media-related outpatient visits in children after PCV10 introduction in Brazil. PLoS One. 2017;12(6):e0179222. doi:10.1371/journal.pone.0179222.
  • Rosenblut A, Rosenblut M, Garcia K, Maul X, Santolaya ME. Frequency of acute otitis media in children under 24 months of age before and after the introduction of the 10-valent pneumococcal conjugate vaccine into the national immunization program in Chile. Pediatr Infect Dis J. 2018;37(2):132–34. doi:10.1097/INF.0000000000001722.
  • Garcia GG, Lopez VM, Perez GG, Hernandez S, Cardinal P, Felix V, Gabastou JM, Camou T. Effect of pneumococcal conjugate vaccination in Uruguay, a middle-income country. PLoS One. 2014;9(11):e112337. doi:10.1371/journal.pone.0112337.
  • Rodriguez-Morales AJ, Granados-Alvarez S, Escudero-Quintero H, Vera-Polania F, Mondragon-Cardona A, Diaz-Quijano FA, Sosa-Valencia L, Lozada-Riascos CO, Escobedo AA, Liseth O, et al. Estimating and mapping the incidence of giardiasis in Colombia, 2009–2013. Int J Infect Dis. 2016;49:204–09. doi:10.1016/j.ijid.2016.06.005.
  • Monasta L, Ronfani L, Marchetti F, Montico M, Vecchi Brumatti L, Bavcar A, Grasso D, Barbiero C, Tamburlini G. Burden of disease caused by otitis media: systematic review and global estimates. PLoS One. 2012;7(4):e36226. doi:10.1371/journal.pone.0036226.